Changes in CD184 and CD195 expression on various monocyte subpopulations in patients with acute pancreatitis during complex treatment with cytoflavin
- 作者: Savchenko A.A.1, Zdzitovetskiy D.E.2, Anisimova E.N.1, Borisov R.N.2, Adilov M.M.2, Borisov A.G.1
-
隶属关系:
- Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
- V. Voino-Yasenetsky Krasnoyarsk State Medical University
- 期: 卷 28, 编号 3 (2025)
- 页面: 659-666
- 栏目: SHORT COMMUNICATIONS
- URL: https://journals.rcsi.science/1028-7221/article/view/319916
- DOI: https://doi.org/10.46235/1028-7221-17147-CIC
- ID: 319916
如何引用文章
全文:
详细
The development of therapies for acute pancreatitis (AP) should consider their immune effects. Monocytes play a key role in innate and adaptive immune responses in AP. Cytoflavin has immunocorrective effects but there are lacking data on its influence on monocyte function. Our aim was to investigate the effect of cytoflavin on CD184 and CD195 expression in monocyte subpopulations during AP treatment. 35 patients (mean age 48.7±5.8 years) with moderate and severe AP were divided into two groups: 18 received standard therapy, 17 received cytoflavin. Blood samples were taken before and after 14 days of treatment. Control group: 32 healthy age-matched individuals. Monocyte subsets were analyzed by flow cytometry. Before the start of treatment, patients with AP showed an increase in the number of CD14+CD16+ monocytes, the level of which normalized after treatment with cytoflavin. The number of CD14++CD16-CD184+ and CD14+CD16+CD184+ monocytes increases in patients with AP before the start of treatment, as does the level of receptor expression on these subsets. The content of monocytes with these phenotypes did not change after standard treatment but increased significantly with cytoflavin treatment. The monocyte subpopulations expressing CD195 were increased in AP patiets before treatment. After therapy with cytoflavin, the level of CD195+ “classical” and “transitional” monocytes decreased, while the level of CD195 expression increased among “transitional” and “non-classical” monocytes. The inflammatory reaction in patients with AP before the start of treatment is characterized by the presence of compensatory processes, due to increased content of monocytes with anti-inflammatory function. Increased numbers of monocytes express CXCR4 and CCR5 during the acute phase of the disease. Conventional therapy doesn’t lead to changes in the subset composition of monocytes and the number of cells expressing CXCR4 and CCR5. After treatment with cytoflavin, the subpopulation profile of monocytes is normalized, a redistribution of migrating monocytes is observed: the content of proinflammatory cells decreases and the level of cells with anti-inflammatory and antigen-presenting activity increases.
作者简介
A. Savchenko
Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
Email: foi-543@mail.ru
PhD, MD (Medicine), Professor, Head, Cellular-Molecular Physiology and Pathology Laboratory
俄罗斯联邦, KrasnoyarskD. Zdzitovetskiy
V. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: foi-543@mail.ru
PhD, MD (Medicine), Professor, Head, Yu. Lubensky Department of Faculty Surgery
俄罗斯联邦, KrasnoyarskE. Anisimova
Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
编辑信件的主要联系方式.
Email: foi-543@mail.ru
PhD (Medicine), Senior Researcher, Cellular-Molecular Physiology and Pathology Laboratory
俄罗斯联邦, KrasnoyarskR. Borisov
V. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: foi-543@mail.ru
PhD (Medicine), Associate Professor, Yu. Lubensky Department of Faculty Surgery
俄罗斯联邦, KrasnoyarskM. Adilov
V. Voino-Yasenetsky Krasnoyarsk State Medical University
Email: foi-543@mail.ru
Assistant Professor, Yu. Lubensky Department of Faculty Surgery
俄罗斯联邦, KrasnoyarskA. Borisov
Research Institute of Medical Problems of the North, Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences
Email: foi-543@mail.ru
PhD (Medicine), Leading Researcher, Cellular-Molecular Physiology and Pathology Laboratory
俄罗斯联邦, Krasnoyarsk参考
- Лемешевская О.И., Сопрун Л.А., Камаева Э.А., Лукашенко М.В., Гаврилова Н.Ю. Роль препарата Цитофлавин в коррекции дизавтономии у больных с постковидным синдромом // Журнал неврологии и психиатрии им. С.С. Корсакова, 2024. Т. 124, № 11. С. 140-146. [Lemeshevskaia O.I., Soprun L.A., Kamaeva E.A., Lukashenko M.V., Gavrilova N.Yu. The role of drug Cytoflavin in the correction of dysautonomia in patients with post-COVID syndrome. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S. Korsakov Journal of Neurology and Psychiatry, 2024, Vol. 124, no. 11, рр. 140-146. (In Russ.)]
- Трулев А.С., Борисов А.Г., Кудрявцев И.В., Лазанович В.А., Савченко А.А. Роль моноцитов в иммунопатогенезе инфекционно-воспалительных заболеваний: от теории к практике // Медицинский академический журнал, 2024. Т. 24, №4. C. 9-32. [Trulioff A.S., Borisov A.G., Kudriavtsev I.V., Lazanovich V.A., Savchenko A.A. Role of monocytes in immunopathogenesis of infectious and inflammatory diseases: from theory to practice. Meditsinskiy akademicheskiy zhurnal = Medical Academic Journal, 2024, Vol. 24, no. 4, рр. 9-32. (In Russ.)]
- Эктов В.Н., Ходорковский М.А., Куркин А.В. Патогенетические аспекты выбора медикаментозной терапии в лечении острого панкреатита // Вестник экспериментальной и клинической хирургии, 2024. Т. 17. № 3. C. 137-146. [Ektov V.N., Khodorkovsky M.A., Kurkin A.V. Pathogenetic aspects of the choice of drug therapy in the treatment of acute pancreatitis. Vestnik eksperimentalnoy i klinicheskoy khirurgii = Journal of Experimental and Clinical Surgery, 2024, Vol. 17, no. 3, рр. 137-146. (In Russ.)]
- Critelli B., Hassan A., Lahooti I., Noh L., Park J.S., Tong K., Lahooti A., Matzko N., Adams J.N., Liss L., Quion J., Restrepo D., Nikahd M., Culp S., Lacy-Hulbert A., Speake C., Buxbaum J., Bischof J., Yazici C., Evans-Phillips A., Terp S., Weissman A., Conwell D., Hart P., Ramsey M., Krishna S., Han S., Park E., Shah R., Akshintala V., Windsor J.A., Mull N.K., Papachristou G., Celi L.A., Lee P. A systematic review of machine learning-based prognostic models for acute pancreatitis: Towards improving methods and reporting quality. PLoS Med., 2025, Vol. 22, no. 2, е1004432. doi: 10.1371/journal.pmed.1004432.
- Liu S., Szatmary P., Lin J.W., Wang Q., Sutton R., Chen L., Liu T., Huang W., Xia Q. Circulating monocytes in acute pancreatitis. Front. Immunol., 2022, Vol. 13, 1062849. doi: 10.3389/fimmu.2022.1062849.
- Padgett L.E., Araujo D.J., Hedrick C.C., Olingy C.E. Functional crosstalk between T cells and monocytes in cancer and atherosclerosis. J. Leukoc. Biol., 2020, Vol. 108, no. 1, pp. 297-308.
- Rawat K., Tewari A., Li X., Mara A.B., King W.T., Gibbings S.L., Nnam C.F., Kolling F.W., Lambrecht B.N., Jakubzick C.V. CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes. J. Exp. Med., 2023, Vol. 220, no. 6, e20222129. doi: 10.1084/jem.20222129.
- Sadri F., Rezaei Z., Fereidouni M. The significance of the SDF-1/CXCR4 signaling pathway in the normal development. Mol. Biol. Rep., 2022, Vol. 49, no. 4, pp. 3307-3320.
- Silina E.V., Rumyantceva S.A., Stupin V.A., Parfenov V.A., Bolevich S.B. Early predictive blood markers of hemorrhagic stroke – influence of cytoflavin therapy. Can. J. Physiol. Pharmacol., 2021, Vol. 99, no. 1, рр. 72-79.
- Xu Y., Song J., Gao J., Zhang H. Identification of biomarkers associated with oxidative stress and immune cells in acute pancreatitis. J. Inflamm. Res., 2024, Vol. 25, no. 17, рр. 4077-4091.
- Yao J., Zhang S., Zhou F., Zhuang M., Fei S. The relationship between inflammatory cytokines and in-hospital complications of acute pancreatitis. Immun. Inflamm. Dis., 2024, Vol. 12, no. 2, e1203. doi: 10.1002/iid3.1203.
补充文件
